Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

New cancer treatments aim to reduce side effects and improve effectiveness.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Imuvert can prevent some chemotherapy-induced hair loss.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Higher doses of cranial irradiation are linked to permanent hair loss.

Cancer prevention has advanced significantly, with some strategies proving successful.

Cetuximab can cause unusual hair growth and hair loss.

Inhibiting ODC can prevent UV-induced skin cancer.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Active oxygen species might be involved in skin tumor growth, but their exact role is unclear.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Recognizing rare tumor combinations is crucial for accurate diagnosis and treatment.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

A woman's symptoms of increased body hair and testosterone were caused by a rare adrenal tumor, which was removed successfully.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.